COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Cardiovascular Genetics

Comprehensive Genetic Evaluation for Heart Disease

Heart disease, including heart attack and stroke, are the leading causes of death in the United States. It is estimated that more than 80 million Americans carry a diagnosis of heart disease. 

There have been remarkable advances over the last several decades to treat heart disease, but despite these advances, there is a very high residual risk of having a cardiac event, with more than 400,000 people each year dying from cardiac-related disorders. While some forms of heart disease take a lifetime to develop, many of the current therapies are started late in life and only after cardiac events have occurred or heart disease has been diagnosed.

Loyola Medicine aims to reduce risk of heart disease and offer early detection through the cardiovascular genetics program, which provides comprehensive diagnostics for all types of inherited heart disease, including:

The cardiovascular genetics program at Loyola aims to prevent the onset or recurrence of heart disease by identifying your genetic factors and providing leading-edge care and prevention. Experts at Loyola use DNA testing to detect gene mutations known to be linked to various forms of genetic heart disease. We provide treatment, risk assessment and risk reduction.

Why Choose Loyola for Cardiovascular Genetics?

Loyola’s world-class doctors and researchers apply advances in research to the care of our patients in state-of-the-art facilities. Loyola will evaluate your condition and develop a customized care plan specific to your needs.

COVID-19 Symptom Checker